The findings in this study mainly apply to DCIS that is grade 2, solid type, associated with calcifications, ER+/HER2–, Ki67 < 14% and in patients that are >50 years old (with unknown clinical presentation in nearly 50%). This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.